corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 15095

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Matheson A.
Corporate Science and the Husbandry of Scientific and Medical Knowledge by the Pharmaceutical Industry
BioSocieties 2008; 3:355–382
http://www.admatheson.com/AM%20BioSocieties%20paper%20Dec%2008.pdf


Abstract:

This article analyses the role of the pharmaceutical and medical device industries (‘pharma’) in
the construction of scientific and medical knowledge. Pharma’s activities are part of the broader
dispositif of institutions, enterprises, regulations and constituencies within which medical-scientific
knowledge is generated, but pharma’s contributions exhibit a specific character reflecting commercial
pressures. As drug development proceeds, research and marketing activities coalesce
around ‘product canons’ that integrate scientific truth-claims and commercial positioning, generating
knowledge with implicit commercial functionality. From this platform, pharma stamps consensus-
building ‘narratives’ into medical-scientific discourse, in which ‘problems’ arise and are
‘solved’ by drugs. Concurrently, pharma modulates the structure of discourse and the social networks
through which discourse proceeds. Implicit within these activities is a meta-science whose
goal is to understand and technologize the operation of science to an external end. This mode
of knowledge production can be viewed as a normative transformation of Kuhnian normal science,
characterized by the attachment (and at times subordination) of paradigmatic tenets to
extrinsic goals; exaggerated control of belief, research and consensus formation; and a capacity
for infringement of traditional norms of scientific truthfulness. An International Standard of Integrity
in Science would strengthen pharma’s contributions to medical and scientific knowledge.

Keywords:
Foucault, Kuhn, Marketing, Medicine, Pharmaceutical Industry, Science Studies

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.